How should you treat trochanteric bursitis? by Rowand, Mark et al.
CLINICAL INQUIRIES Evidence Based Answers from the Family Physicians 
Inquiries Network
494 VOL 58, NO 9 / SEPTEMBER 2009  THE JOURNAL OF FAMILY PRACTICE
FAST TRACK
  Evidence-based answer
Conservative measures—followed by 
corticosteroid injection, if necessary—are 
best. Conservative therapy includes rest, 
nonsteroidal anti-infl ammatory drugs 
(NSAIDs), and stretching exercises focused 
on the lower back and sacroiliac joints 
(strength of recommendation [SOR]: C, 
usual practice). Patients whose symptoms 
persist despite conservative therapy are 
likely to benefi t from an injection of 24 mg 
betamethasone and 1% lidocaine (or 
equivalent) into the infl amed bursa (SOR: B, 
limited-quality, patient-oriented evidence). 
In rare cases of intractable symptoms, 
surgical procedures such as iliotibial 
band release, subgluteal bursectomy, 
and trochanteric reduction osteotomy are 
options (SOR: C, case studies). 
How should you treat 
trochanteric bursitis?
❚ Evidence summary
Trochanteric bursitis is characterized 
by chronic intermittent lateral hip pain 
caused by infl ammation of the trochan-
teric bursae. The bursae can become 
infl amed at the gluteus medius tendon, 
iliotibial tract, or gluteus minimus during 
repetitive fl exing of the hip. Several con-
ditions are associated with trochanteric 
bursitis (TABLE). 
Trochanteric bursitis peaks in the 
fourth to sixth decades of life. One ret-
rospective cohort study found the preva-
lence to be 1.8 cases per 1000 patients 
per year in primary care; 79% of cases 
occurred in women.1 
No studies have compared 
conservative treatments
Most review articles refer to initial treat-
ment with rest, physical therapy, stretch-
ing, and NSAIDs. These treatments were 
described in textbooks and articles from 
the 1940s and 1950s. 
No studies comparing conservative 
treatments were found. Few reports dis-
cuss physical therapy for trochanteric 
bursitis.
Corticosteroid injection has 
the best evidential support
Corticosteroid injection for treating tro-
chanteric bursitis is supported by the best 
evidence in the available literature. No 
controlled trials have compared injection 
with placebo, however. 
A randomized, prospective, open 
comparison trial at a rheumatology clinic 
assigned patients with trochanteric bur-
sitis to 6-, 12-, or 24-mg doses of beta-
methasone mixed with 1% lidocaine.2 
Seventy-seven percent of patients had 
improved at 1 week, 69% at 6 weeks, 
and 61% at 26 weeks. Notably, a signifi -
cant difference was found at 26 weeks in 
the number of patients with sustained 
pain improvement who had received 
24 mg of steroid (P<.0123) compared 
with patients who received the lower dos-
es. The authors didn’t report side effects 
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Initial treatment 
includes rest, 
NSAIDs, and 
stretching 
exercises focused 
on the lower back 
and sacroiliac 
joints.
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of 164 British patients found that those 
who received a corticosteroid injection 
were 2.7 times more likely to have re-
covered at 5 years than patients who had 
not received an injection (odds ratio=0.4; 
95% confi dence interval, 0.1-1.0).1
When to consider surgery
Surgical treatment may be necessary for 
patients with refractory trochanteric bur-
sitis. Several case studies5-7 demonstrate 
successful outcomes with a variety of 
surgical techniques, including trochan-
teric reduction osteotomy and iliotibial 
band release. Newer techniques involve 
arthroscopic bursectomy.
Recommendations
UpToDate8 recommends conservative 
treatment initially. For persistent cases, a 
corticosteroid injection should be given 
and repeated in 6 weeks if pain persists. 
Surgery may be considered if these mea-
sures don’t relieve symptoms and pain 
lasts longer than 1 year.
The American Academy of Ortho-
paedic Surgeons similarly recommends 
NSAIDs and activity modifi cation fol-
lowed by corticosteroid injection.9 Sur-
gery is rarely indicated. ■
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or complications. 
A prospective, noncomparative co-
hort study investigated 72 patients in 
a rheumatology clinic who hadn’t im-
proved after at least 2 weeks of treat-
ment with NSAIDs, analgesics, or oint-
ments.3 Of the 59 patients who consented 
to steroid injections, 42 improved af-
ter 1 injection of 40 mg methylpred-
nisolone with 2 mL of 2% lidocaine, 
13 improved after a second injection 
3 weeks later, and the remaining 4 im-
proved after a third injection. Improve-
ment was defi ned as disappearance of 
pain and disability. Six patients (8%) ex-
perienced a recurrence of bursitis during a 
2-year follow-up period. No local or sys-
temic complications were associated with 
the corticosteroids or anesthetic solution.
Two retrospective studies also docu-
mented the effi cacy of corticosteroid 
injection. One investigated treatment 
of 36 patients in a rheumatology prac-
tice.4 All received methylprednisolone 
(40-80 mg) or triamcinolone (20-40 mg), 
and all improved. Two thirds of the pa-
tients were symptom free after 1 or 2 in-
jections. Symptoms usually resolved with-
in 2 days to several months (typically 1 or 
2 weeks) postinjection. About 25% of the 
patients relapsed within 2 years. 
Another retrospective cohort study 
Conditions associated with trochanteric bursitis
Chronic mechanical low back pain
Degenerative arthritis or disc disease of lower lumbar spine
Degenerative joint disease of knees
Fibromyalgia
Iliotibial band syndrome
Infl ammatory arthritis of the hip
Ipsilateral or contralateral hip arthritis
Leg length discrepancy
Obesity
Pes planus
Tendonitis of external hip rotators
Total hip arthroplasty
Source: Lievense A et al. Br J Gen Pract. 2005.1 
TABLE
Patients whose 
symptoms 
persist are likely 
to beneﬁ t from an 
injection of 24 mg 
betamethasone 
and 1% lidocaine 
into the inﬂ amed 
bursa.
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